Antigen Information
General Information of This Antigen
| Antigen ID | TAR0IBZAS |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Claudin-18.2 (CLDN18.2) |
|||||
| Gene Name | CLDN18.2 |
|||||
| Gene ID | ||||||
| Sequence |
MSTTTCQVVAFLLSILGLAGCIAATGMDMWSTQDLYDNPVTSVFQYEGLWRSCVRQSSGF
TECRPYFTILGLPAMLQAVRALMIVGIVLGAIGLLVSIFALKCIRIGSMEDSAKANMTLT SGIMFIVSGLCAIAGVSVFANMLVTNFWMSTANMYTGMGGMVQTVQTRYTFGAALFVGWV AGGLTLIGGVMMCIACRGLAPEETNYKAVSYHASGHSVAYKPGGFKASTGFGSNTKNKKI YDGGARTEDEVQSYPSKHDYV Click to Show/Hide
|
|||||
| Family | CD99 family |
|||||
| Function |
Involved in alveolar fluid homeostasis via regulation of alveolar epithelial tight junction composition and therefore ion transport and solute permeability, potentially via downstream regulation of the actin cytoskeleton organization and beta-2-adrenergic signaling. Required for lung alveolarization and maintenance of the paracellular alveolar epithelial barrier. Acts to maintain epithelial progenitor cell proliferation and organ size, via regulation of YAP1 localization away from the nucleus and thereby restriction of YAP1 target gene transcription. Acts as a negative regulator of RANKL-induced osteoclast differentiation, potentially via relocation of TJP2/ZO-2 away from the nucleus, subsequently involved in bone resorption in response to calcium deficiency. Mediates the osteoprotective effects of estrogen, potentially via acting downstream of estrogen signaling independently of RANKL signaling pathways.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
5103F3
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
BL-M05D1
|
Ed-04 |
DNA topoisomerase 1 (TOP1) |
Gly-Mal-Gly-Gly-Phe-Gly |
Anti-CLDN18.2 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
DA-3501
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Elatatug vedotin
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
A cleavable linker |
|
|
BDC-4182
|
Undisclosed |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
A non-cleavable linker |
|
|
XNW27011
|
YL0010014 |
DNA topoisomerase 1 (TOP1) |
VK*G-NHCH2-O linker |
|
|
SO-N102
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Pentaglycine-EDA uncleavable linker |
|
|
ATG-022
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
PR301
|
Duostatin 5 |
Microtubule (MT) |
A cleavable linker |
|
|
SKB315
|
Belotecan-derivative |
DNA topoisomerase 1 (TOP1) |
Kthiol (pyrimidine-thiol) oligopeptide linker |
|
|
SIBP-A18
|
DXd |
DNA topoisomerase 1 (TOP1) |
Mc-VASGFG |
|
|
AZD4360
|
TOP1 inhibitor |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
Anti-CLDN18.2 IgG1 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TQB2103
|
2-DDDX-d |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Anti-CLDN18.2 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Arcotatug tavatecan
|
Exatecan |
DNA topoisomerase 1 (TOP1) |
Synaffix linker |
|
|
JS107
|
Monomethyl auristatin E |
Microtubule (MT) |
Maleimide linker of vc PAB |
|
|
CN107667118A ADC-1
[2]
|
CN107667118A ADC-1 linker payload |
Undisclosed |
CN107667118A ADC-1 linker |
|
|
CN107667118A ADC-2
[2]
|
CN107667118A ADC-2 linker payload |
Undisclosed |
CN107667118A ADC-2 linker |
Anti-CLDN18.2 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SYSA1801
|
Monomethyl auristatin E |
Microtubule (MT) |
PEG3-Val-Cit-PABC |
Ciletatug
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Ciletatug vedotin
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
CM311-18A9-VH7/VL2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CM311-18A9-VH7/VL2-ADC
[3]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
CM311-18D10-VH3/VL2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CM311-18D10-VH3/VL2-ADC
[3]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
CM311-18D10-VH6/VL1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CM311-18D10-VH6/VL1-ADC
[3]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
CM311-18D10-VH6/VL2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CM311-18D10-VH6/VL2-ADC
[3]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
Garetatug
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Garetatug rezetecan
|
SHR9265 |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
h1902-11
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2021115426A1 ADC-2
[4]
|
WO2021115426A1 ADC-2 payload |
Undisclosed |
WO2021115426A1 ADC-2 linker |
|
|
WO2021115426A1 ADC-3
[4]
|
WO2021115426A1 ADC-3 payload |
Undisclosed |
WO2021115426A1 ADC-3 linker |
|
|
WO2021115426A1 ADC-4
[4]
|
WO2021115426A1 ADC-4 payload |
Undisclosed |
WO2021115426A1 ADC-4 linker |
|
|
WO2021115426A1 ADC-5
[4]
|
WO2021115426A1 ADC-5 payload |
Undisclosed |
WO2021115426A1 ADC-5 linker |
h1902-5
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2021115426A1 ADC-1
[4]
|
WO2021115426A1 ADC-1 payload |
Undisclosed |
WO2021115426A1 ADC-1 linker |
|
|
WO2021115426A1 ADC-6
[4]
|
WO2021115426A1 ADC-6 payload |
Undisclosed |
WO2021115426A1 ADC-6 linker |
|
|
WO2021115426A1 ADC-7
[4]
|
WO2021115426A1 ADC-7 payload |
Undisclosed |
WO2021115426A1 ADC-7 linker |
|
|
WO2021115426A1 ADC-8
[4]
|
WO2021115426A1 ADC-8 payload |
Undisclosed |
WO2021115426A1 ADC-8 linker |
|
|
WO2021115426A1 ADC-9
[4]
|
WO2021115426A1 ADC-9 payload |
Undisclosed |
WO2021115426A1 ADC-9 linker |
H239H-2b-K-6a-1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN115429893A ADC8
[5]
|
CN115429893A ADC3 Payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
|
|
CN115429893A ADC9
[5]
|
CN115429893A ADC3 Payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
|
|
CN115429893A ADC10
[5]
|
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
|
|
CN115429893A ADC11
[5]
|
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
|
|
CN115429893A ADC12
[5]
|
CN115429893A ADC2 Payload |
Undisclosed |
CB07 linker |
H239H-2b-K-6a-2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN115429893A ADC13
[5]
|
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
|
|
CN115429893A ADC14
[5]
|
CN115429893A ADC1 Payload |
Undisclosed |
CB07 linker |
hCL1a
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1a-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1b
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1b-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1c
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1c-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1d
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1d-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1e
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1e-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1f
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1f-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1g
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1g-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1h
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1h-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1i
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1i-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
hCL1j
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
hCL1j-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
HClaudin18.2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LCB02A
|
PR301839 |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
IMAB362
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
IMAB362-Val-Cit-MMAE
[7]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
IMAB362-MC-Val-Cit-PAB-MMAE
[8]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
IMAB362-LC-G2-PNU
[6]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
IMAB362-DM4
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
IMAB362-vCMMAE
|
Undisclosed |
Undisclosed |
Undisclosed |
RGCLN18.2
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
RGCLN18.2-MC-Val-Cit-PAB-MMAE
[8]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
RGCLN18.2-D07-Val-Cit-PAB-MMAE
[8]
|
Monomethyl auristatin E |
Microtubule (MT) |
D07-Val-Cit-PABC |
|
|
RGCLN18.2-PY-Val-Cit-PAB-MMAE
[8]
|
Monomethyl auristatin E |
Microtubule (MT) |
PY-VC-PABC |
Sonesitatug
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Sonesitatug vedotin
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
SYM003 (anti-Claudin 18.2)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024169913A1 ADC03-01-8
[9]
|
B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
(Linker-03)SMCC-TAZ-PEG-VC-PAB |
|
|
WO2024169913A1 ADC03-01-4
[9]
|
B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Cit-PABC |
Tecotabart
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Tecotabart vedotin
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
Zolbetuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN118873678A ADC-17
[10]
|
undisclosed |
Undisclosed |
Undisclosed |
|
|
CN118873678A ADC-18
[10]
|
Undisclosed |
Undisclosed |
Undisclosed |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LNL-008
[11]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
BSI-706
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
BSI-077
[13]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
MIL-106
[14]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Alpha-CLDN-VC0101
[15]
|
Auristatin 0101 |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
CPO-102
[16]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
|
|
alphaCLDN18.2-MMAE
[17]
|
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
References
